Tympanogen, EVMS, and VCU have won their second Virginia Catalyst grant. The award of $737,000 will support the first-in-human study for Tympanogen's Perf-Fix Otologic Gel Patch for nonsurgical eardrum repair. Both EVMS and VCU will be study sites, highlighting the Commonwealth's capabilities for commercial research.

Governor Ralph Northam today announced $2.48 million in funding to support 26 small technology-based businesses and four universities in commercializing their research, leveraging more than $13 million in matching investments.

Tympanogen, a medical device startup based in Richmond, VA, was awarded nearly $250,000 as a Small Business Innovation Research (SBIR) contract from the Department of Defense (DOD).

Governor Ralph Northam today announced that non-profit corporation Virginia Catalyst has awarded $3.3 million in grants to six innovative life science and bioscience collaborations.

A startup company in the Virginia Bio+Tech Park in Richmond has moved one step closer to realizing a new medical treatment for eardrum repairs.